Company profile:
Mainly dedicated to the manufacture of cephalosporin medicines, Tianjin Shin Poong Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise jointly set up by Tianjin Zhongxin Pharmaceutical Group and Korean Shin Poong Pharmaceutical Co., Ltd. The company lies in Tianjin Economic-Technological Development Area (TEDA) which is situated to the west of the Bohai Bay. It covers an area of nearly 30 thousands square meters, with its registered capital being around US$9,000,000. Its first phase project spent about 80,000,000Yuan, in which the Chinese side invested 55% and Korean side invested 45%. The factory building was finished in Jun. 2000. Its scope of business involves operating the production, processing and sale of troches, capsules and powder medicine for injection.
Its plant has a beautiful environment and reasonable holistic layout which demonstrate the unique style of this modern pharmaceutical enterprise. It has passed a strict inspection and appraisal by the State Food and Drug Administration (SFDA). In October 1999, it passed the GMP static certification at one time and in April 2001, it passed GMP dynamic certification at one time.
The main production equipment and detection apparatuses used in the factory have all been purchased from the USA, Europe, Japan and Korea. Now, the factory has three production lines for manufacturing troche, capsule and cephalosporin powder medicine for injection. Among them, the production of the powder medicine for injection has filled a gap in Tianjin. Now the company has become one of the leading manufacturers of cephalosporin antibiotic drugs in Northern China.
Acquiring a strong market concept and competition awareness, the company has employed modern enterprise management theories. Guided by a scale management concept, it has devoted to the creation of a high efficiency, thus enjoying an exponential development. From 2000 to 2002, its annual sales increased 288.7% per annum averagely, which ranked among the top ones in the medicine industry of Tianjin. Since 2003, its output and sales have maintained a powerful increase continuously. It is expected that its per capita sales avenue will achieve 991,700Yuan, an increase of 69.35% compared with the same period last year. Its per capita interest and tax will reach 128,100Yuan, an increase of 177.4% compared with the same period last year.
Tianjin Shin Poong has introduced international advanced production equipment and advanced technologies. It has strictly followed GMP standards while organizing production. It has also enhanced quality control in all its processes, thus completely guaranteeing the high quality of its products, thanks to which it has won the trusts of numerous customers.
Being market-oriented and adapting to market demands, the company has served customers warmly. It has carried out academic spread activities and academic consultation services widely, thus increase the social popularity of its products and expanding its market share. Now its products have been sold in 30 provinces, cities and regions of China.
The company boasts an outstanding market development capability and has established a high quality and highly efficient sales team, which has contributed to a perfect sales network system and promoted the in-depth development of the product market.
The company regards talent resources as its primary strategic resources and has employed many talents. Under its flag gather a great many high level professional technical personnel, including intermediate and senior ones who account for 1/4 of the total employees, as well as those who graduated from colleges and universities, who account for nearly 2/3 of the total employees.
Based on science and technology invention and aiming at serving the human health undertaking by developing and producing quality and specific products, it has increased its investment in scientific research repeatedly to develop new products, which have been released to the market one by one. Its TEZACEF --one of the new cephalosporin drugs at national level, has been first developed in the country. Its Cepha. 3rd antibiotics AROCEF, which was developed early, has satisfied market demands on medicines for treating encephaloous infection. Its Ceftazidime and Ceftriaxone have become cephalosporin drug families. Among them, TEZACEF and AROCEF have been widely used for clinical treatment owing to their excellent antibacterial activity and proven therapeutic effects. Now, they have become our leading products.
The company pays attention to cultural construction and insists on making inventions in management, technology and product so as to inject vitality time and again. It has molded a quality image and cultivated a quality awareness meticulously, trying to realize Zero Defect in product quality and seek for high quality unremittingly. It has been adhering to high quality standards all the time and its quality indexes are on the high side compared with the same products, hence its "quality for victory" competitive edges.
Tianjin Shin Poong concentrates on the cultivation of a team spirit among its employees. It has enhanced its cohesion and built up a strong sense of acceptance and attachment among its employees. Its employees have created a convincingly high efficiency. They have contributed to the rapid development of the company, as well as reflected their values and those of the enterprise.
Inheriting the "nature and man are of the same sequence and bringing benefits to the people" concept which has been advocated by Tianjin Zhongxin Pharmaceutical Group, the company has gone with the trend of development of the times to serve the human health cause with the spirit of creating excellence and sincere dedication.
Key products:
Now, our company mainly produces and sells the following three products:
¢ñ.TEZACEF¡ªCeftezole sodium for Injection
It is a kind of broad-spectrum Cephalosporin Antibiotics
Composition : Each vial contains Ceftezole sodium------------------ 500mg or 1g(potency)
Characteristic :It is stable for resistant staphylococcus and beta-lactamase generated by G(-). It has excellent tolerance to infant and the aged by minimizing adverse effect.
Indications : Septicemia, pneumonia, bronchitis, bronchiectasis in the Infection stage pulmonary suppuration, peritonitis, pyelonephritis, cystitis, urethritis.
Dosage and Administration :5g~0.4g(potency)divided in 1 or 2times, I.V. or I.M.
Expiry : 2years How supplied : 1vial + 1diluent
¢ò.AROCEF-- Ceftizoxime Sodium for Injection
It is a kind of Cephalosporin Antibiotics
Composition : Each vial contains Ceftizoxime sodium-------------500mg or 1g(potency)
Characteristic : It has broad antibacterial spectrum. It shows specially strong antibacterial effect against G(-).
Indications : Sepsis, infectious endocarditis, secondary infections of wounds or burns, bronchitis, infected bronchiectasis, secondary infections of chronic respiratory tract disease, cholecystitis, peritonitis, pyelonephritis, cystitis, prostatitis, etc.
Dosage and Administration :For adults : 0.5~2g(potency)/day in 2~4 divided doses I.V.
For children : 40~80mg(potency)/kg/day in 2~4 divided doses I.V.
Expiry : 24 months How supplied : 1vial + 1diluent
¢ó.XILOFEN¡ªLoxoprofen Sodium Tablet
Loxoprofen sodium is an anti-inflammatory analgesic drug used for the management of pain and inflammation assosiated with muscle skeletal and joint disorder or operative procedures.
Contact Information:
Contact: Headquarters--Mr. JIN or Mr. QIU Marketing & Sales Department--Madam Zhang & Madam CHU
Tel: Headquarters 86-22-66200662 Marketing & Sales Department 86-22-27486053
Fax: Headquarters 86-22-66200661 Marketing & Sales Department 86-22-27486054